glp 1 long covid GLP-1 Treatments Show Promise for Symptoms GLP-1 Drugs For Long COVID:

Akter MM et al

The protocols raise many issues that are subject to change as new data emerge

According to Leerink analyst David Reisinger, retatrutide showed higher gastrointestinal side effects than Zepbound, as expected, plus much higher rates of dysesthesia. William Blairs Andy Shea acknowledged that the placebo-adjusted weight loss compares favourably to the 18% figure for Zepbound but predicted the drug will likely be limited to individuals at the higher end of the BMI spectrum. In plain terms: retatrutide works spectacularly, but its probably too punishing for routine use

Now, a new trend is emerging from the fringes: GLP-1 microdosing

E.Rosell-CatafauJ.PintX.MitjavilaM